AG
IRMD icon

Advisor Group’s iRadimed IRMD Stock Holding History

Advisor Group’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$18K Hold
750
– – ﹤0.01% 4020
2019
Q3 		$16K Sell
750
-1,000
-57% -$20.4K ﹤0.01% 4096
2019
Q2 		$36K Sell
1,750
-500
-22% -$11.8K ﹤0.01% 3580
2019
Q1 		$63K Hold
2,250
– – ﹤0.01% 3223
2018
Q4 		$55K Sell
2,250
-700
-24% -$18.8K ﹤0.01% 3114
2018
Q3 		$110K Buy
+2,950
New +$79.6K ﹤0.01% 2692
2017
Q3 		– Sell
-450
Closed -$4K – 4898
2017
Q2 		$4K Hold
450
– – ﹤0.01% 4325
2017
Q1 		$4K Buy
+450
New +$4.17K ﹤0.01% 4204

Other funds holding IRMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

Advisor Group's IRMD Position: Q4 2019 in Review

Advisor Group held its iRadimed (IRMD) position steady in Q4 2019 at 750 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #4020.

Advisor Group first reported a position in IRMD in Q1 2017 and has held it in 8 quarters since. The position peaked at $110K in Q3 2018. 64 funds tracked by Wall St. Rank hold IRMD as of Q4 2019.

  • Advisor Group held 750 shares of iRadimed worth $18K as of Q4 2019.
  • Advisor Group left its iRadimed share count unchanged in Q4 2019.
  • iRadimed made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4020 holding.
  • Advisor Group first reported a position in iRadimed in Q1 2017 and has held it in 8 quarters since.
  • Advisor Group's iRadimed position peaked at $110K in Q3 2018.
  • 64 funds tracked by Wall St. Rank held iRadimed as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.